These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 16917833)

  • 41. Propagation of biochirality: crossovers and nonclassical crystallization kinetics of aspartic acid in water.
    Lee T; Lin YK; Tsai YC; Lee HL
    Chirality; 2013 Nov; 25(11):768-79. PubMed ID: 23873735
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Resolution of Racemic Guaifenesin Applying a Coupled Preferential Crystallization-Selective Dissolution Process: Rational Process Development.
    Temmel E; Eicke MJ; Cascella F; Seidel-Morgenstern A; Lorenz H
    Cryst Growth Des; 2019 Jun; 19(6):3148-3157. PubMed ID: 32952448
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Experimental evidence and theoretical analysis for the chiral symmetry breaking in the growth front of conglomerate crystal phase of 1,1'-binaphthyl.
    Asakura K; Plasson R; Kondepudi DK
    Chaos; 2006 Sep; 16(3):037116. PubMed ID: 17014250
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Separation of non-racemic mixtures of enantiomers: an essential part of optical resolution.
    Faigl F; Fogassy E; Nógrádi M; Pálovics E; Schindler J
    Org Biomol Chem; 2010 Mar; 8(5):947-59. PubMed ID: 20165781
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Heterocomplexation of a chiral dipeptide and quantitative enantiomeric enrichment of nonracemic 1,1'-bi-2-naphthol.
    Shan Z; Xiong Y; Yi J; Hu X
    J Org Chem; 2008 Nov; 73(22):9158-60. PubMed ID: 18939866
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Predicting the relative solubilities of racemic and enantiopure crystals by density-functional theory.
    Otero-de-la-Roza A; Cao BH; Price IK; Hein JE; Johnson ER
    Angew Chem Int Ed Engl; 2014 Jul; 53(30):7879-82. PubMed ID: 24917528
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Preferential enrichment: significant influence of minor molecular modification on the mode of polymorphic transition during crystallization.
    Fujimoto D; Takahashi H; Ariga T; Tamura R
    Chirality; 2006 Feb; 18(3):188-95. PubMed ID: 16432918
    [TBL] [Abstract][Full Text] [Related]  

  • 48. New resolution of 2-formyl-1,4-dhp derivatives using CIDR methodology. Facile access to new chiral tricyclic thiolactam.
    Marchalín S; Cvopová K; Kriz M; Baran P; Oulyadi H; Daïch A
    J Org Chem; 2004 Jun; 69(12):4227-37. PubMed ID: 15176852
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Solid-Phase and Oscillating Solution Crystallization Behavior of (+)- and (-)-N-Methylephedrine.
    Tulashie SK; Polenske D; Seidel-Morgenstern A; Lorenz H
    J Pharm Sci; 2016 Nov; 105(11):3359-3365. PubMed ID: 27659160
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Preferential Enrichment of DL-Leucine Using Cocrystal Formation With Oxalic Acid Under Nonequilibrium Crystallization Conditions.
    Manoj K; Takahashi H; Morita Y; Gonnade RG; Iwama S; Tsue H; Tamura R
    Chirality; 2015 Jul; 27(7):405-10. PubMed ID: 25683517
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Reversal of elution order for profen acid enantiomers in normal phase LC on Chiralpak AD.
    Gyllenhaal O; Stefansson M
    J Pharm Biomed Anal; 2008 Apr; 46(5):860-3. PubMed ID: 17499474
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Enantiomer separation of alpha-hydroxy acids in high-performance immunoaffinity chromatography.
    Franco EJ; Hofstetter H; Hofstetter O
    J Pharm Biomed Anal; 2008 Apr; 46(5):907-13. PubMed ID: 18022339
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Resolution of chiral molecules of pharmaceutical interest by means of preferential crystallization].
    Coquerel G
    Ann Pharm Fr; 2009 Jul; 67(4):256-64. PubMed ID: 19596099
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Fluorous "racemic" mixture synthesis: polysaccharide-based chiral columns for simultaneous demix and enantioseparation of racemic fluorous tagged compounds.
    Tonoi T; Zhang W; Curran DP; Mikami K
    Chirality; 2008 Mar; 20(3-4):597-603. PubMed ID: 18205199
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Diastereomeric resolution of racemic o-chloromandelic acid.
    Wang P; Zhang E; Zhao P; Ren QH; Guan YY; Liu HM
    Chirality; 2012 Dec; 24(12):1013-7. PubMed ID: 22730179
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Screening and immobilization Burkholderia sp. GXU56 lipase for enantioselective resolution of (R,S)-methyl mandelate.
    Wei HN; Wu B
    Appl Biochem Biotechnol; 2008 Apr; 149(1):79-88. PubMed ID: 18350389
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Autocatalytic enantiomerisation at the crystal surface in deracemisation of scalemic conglomerates.
    Wei S; Mauksch M; Tsogoeva SB
    Chemistry; 2009 Oct; 15(39):10255-62. PubMed ID: 19693755
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Enantioselective liquid-liquid extraction of zopiclone with mandelic acid ester derivatives.
    Peng Y; He Q; Zuo B; Niu H; Tong T; Zhao H
    Chirality; 2013 Dec; 25(12):952-6. PubMed ID: 24123425
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Racemic compound against racemic conglomerate formation: the crystal properties of allylbenzylmethylphenylphosphonium iodide as compared with the nitrogen analogue.
    Bredikhin AA; Eliseenkova RM; Bredikhina ZA; Dobrynin AB; Kostyanovsky RG
    Chirality; 2009 Jul; 21(7):637-41. PubMed ID: 18853466
    [TBL] [Abstract][Full Text] [Related]  

  • 60. In situ immobilization of a general resolving agent on the magnetic multi-wall carbon nanotube for the direct enantioenrichment of DL-mandelic acid.
    Tarigh GD; Shemirani F
    Talanta; 2015 Nov; 144():899-907. PubMed ID: 26452906
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.